
    
      This study is aimed to be conducted in randomised controlled trial, comparing between
      intervention group and placebo group. We include women with primary dysmenorrhea who also
      have low vitamin D level in this trial. Our primary outcome is to compare visual analog pain
      scale between intervention and placebo group after treatment. After randomised and allocated,
      these women will be given vitamin D 50,000 IU or placebo capsules orally weekly for 8
      consecutive weeks. We monitor pain score daily from the cycle before the drugs started until
      complete 8-week course of the regimen mentioned. Also vitamin D levels will be monitored
      twice, one before treatment and the other after treatment.
    
  